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Abstract
Background: Epidemiological studies have linked maternal infection during pregnancy to later development of
neuropsychiatric disorders in the offspring. In mice, experimental inflammation during embryonic development impairs
behavioral and cognitive performances in adulthood. Synaptic dysfunctions may be at the origin of cognitive impairments,
however the link between prenatal inflammation and synaptic defects remains to be established.
Methodology/Principal Findings: In this study, we show that prenatal alteration of microglial function, including
inflammation, induces delayed synaptic dysfunction in the adult. DAP12 is a microglial signaling protein expressed around
birth, mutations of which in the human induces the Nasu-Hakola disease, characterized by early dementia. We presently
report that synaptic excitatory currents in mice bearing a loss-of-function mutation in the DAP12 gene (DAP12
KI mice)
display enhanced relative contribution of AMPA. Furthermore, neurons from DAP12
KI P0 pups cultured without microglia
develop similar synaptic alterations, suggesting that a prenatal dysfunction of microglia may impact synaptic function in the
adult. As we observed that DAP12
KI microglia overexpress genes for IL1b, IL6 and NOS2, which are inflammatory proteins,
we analyzed the impact of a pharmacologically-induced prenatal inflammation on synaptic function. Maternal injection of
lipopolysaccharides induced activation of microglia at birth and alteration of glutamatergic synapses in the adult offspring.
Finally, neurons cultured from neonates born to inflamed mothers and cultured without microglia also displayed altered
neuronal activity.
Conclusion/Significance: Our results demonstrate that prenatal inflammation is sufficient to induce synaptic alterations
with delay. We propose that these alterations triggered by prenatal activation of microglia provide a cellular basis for the
neuropsychiatric defects induced by prenatal inflammation.
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Introduction
Epidemiological data suggest that maternal infection during
pregnancy increases the risk of neuropsychiatric disorders such as
schizophrenia and autism in the offspring [1,2]. These public
health studies are supported by experimental data in rodents
showing that maternal inflammation during fetal development
impairs the behavior and social interactions of the adult offspring
[3–5]. The mechanisms that link a transient prenatal inflammation
with delayed impairment of neuronal functions have begun to be
investigated at the cellular and molecular levels. The symptoms
detected in the offspring after injection of inflammatory or
infectious agents into pregnant dams are due to the inflammatory
response itself, rather than to chemicals, bacteria, or viruses [1,3].
Recently, in a model mimicking a maternal viral infection, the
behavioral alterations in the progeny were prevented by systemic
injection of blocking antibodies against interleukin-6 [5]. This
reinforces the hypothesis that the deleterious effects arise from the
reaction of the immune system, rather that from the inflammatory
agent itself. Moreover, several groups have found modifications of
protein and mRNA levels of various cytokines and neurotrophic
factors in the offspring [4–7], suggesting that the immune system
of the embryos also contributes to inflammation. The role of
microglia in this process has been little addressed [8].
Some cellular bases for impaired brain functions in adult
offspring following a prenatal infection have been proposed. For
instance, neurogenesis and apoptosis are altered in the adult
offspring [4], and morphological damages have been reported
[9,10]. However, whereas it is now accepted that synaptic
dysfunctions are responsible for the cognitive impairments
observed in psychiatric disorders or neurodegenerative diseases
[11], the structure and function of synapses following embryonic
inflammation have not yet been investigated. We previously
reported a link between immune system impairment and synaptic
PLoS ONE | www.plosone.org 1 July 2008 | Volume 3 | Issue 7 | e2595dysfunction, after having found an enhanced synaptic plasticity
and an altered composition of synaptic AMPA receptors in mice
mutated on a microglial gene [12]. These mice, DAP12
KI
(previously referred to as KD75 mice [13]) carry a loss-of-function
mutation in the gene encoding DAP12, a 12 kD transmembrane
signaling adaptor for a family of innate immunoreceptors. In the
immune system, DAP12 regulates the activation of peritoneal or
bone-marrow-derived macrophages [14–16]. In the brain, DAP12
is transiently expressed by developing microglia [12], and its
expression can be reinduced in adult upon pathological conditions
[17–19]. In culture, DAP12 also controls the phagocytic activity of
microglia and the inflammatory response following neuronal death
[20]. In humans, DAP12 mutations induce Nasu-Hakola disease
(OMIM 221770), characterized by early dementia without any
apparent neuronal damage [21].
Microglia are the instrumental cells of brain inflammation,
therefore we investigated here the relationship between prenatal
activation of microglia and alteration of synaptic function. We first
demonstrated that the ratio between AMPA and NMDA receptor
(AMPAR, NMDAR) currents is increased in adult DAP12
KI mice,
as compared to wild-type (WT). Then, by analyzing pure neuronal
cultures from DAP12
KI P0 pups, we investigated the impact of the
prenatal period in inducing late synaptic defects. Finally, as we
observed that DAP12
KI animals displayed a transient microglial
activation at birth, we compared their synaptic phenotype with the
one of WT animals having experienced a pharmacologically-
induced inflammation during their fetal development. We
conclude from both genetical and pharmacological models that
prenatal activation of microglia has a delayed impact on synaptic
function.
Results
Mutation of the microglial protein DAP12 enhances
relative AMPAR contribution to glutamatergic
transmission in the hippocampus
We previously reported that in the synapses of the Schaffer
collaterals onto CA1 pyramidal neurons of DAP12
KI mice, the
NMDA receptors (NMDARs) were more sensitive to the NR2B-
specific antagonist ifenprodil, and the AMPARs were more
permeable to calcium, as compared with WT mice [12].
Noteworthy, in synapses formed by dentate gyrus granule cells
onto interneurons, it has been shown that Ca
2+-permeable
AMPARs and high content of NR2B in NMDAR result in an
enhanced contribution of AMPAR to the glutamatergic response,
with high ratio of AMPAR- versus NMDAR-evoked excitatory
post-synaptic currents (EPSC) [22]. Thus, in order to further
understand the consequence of DAP12 mutation on synaptic
function, we have now addressed the relative contribution of
AMPAR vs. NMDAR EPSCs in the Schaffer collateral synapses
formed onto CA1 pyramidal neurons in DAP12
KI mice. In WT
mice, the ratio of AMPAR- over NMDAR-mediated currents was
0.2360.05 (n=9), while in DAP12
KI mice, this ratio was
enhanced ,2-fold (Fig 1A; DAP12
KI: 0.4560.08; n=10;
p,0.03). Thus, the relative contribution of AMPAR vs. NMDAR
to glutamatergic currents is increased in the hippocampus of
mutant mice. With electron microscopy analysis, we found that the
synaptic density was unchanged in the hippocampus of DAP12
KI
mice (supplementary data, Fig S1B), but the density of perforated
synapses was significantly increased in the stratum radiatum of
their CA1 area (supplementary data, Fig S1CD). This is consistent
with the enhanced AMPAR/NMDAR ratio in DAP12
KI
hippocampus, since perforated synapses are more enriched in
AMPARs than in NMDARs [23].
Mutation of the microglial protein DAP12 has a delayed
impact on synaptic function
The above-described results raise a temporal paradox. DAP12
mutation impacts glutamatergic transmission in the adult, but we
previously demonstrated that it ceases to be expressed in the
hippocampus at this age [12]. To solve this paradox, we examined
more precisely the expression pattern of DAP12 in developing
hippocampus of WT mice (Fig 1B). At E17, microglia were sparse
and mostly ameboid. A majority displayed DAP12 immunoreac-
tivity, albeit at low level. At P0, the density of microglia increased,
and most displayed a bright immunostaining for DAP12. Between
P0 and P3, the microglia became ramified and the fraction of
DAP12-expressing microglia decreased. At P7, microglia were
mostly ramified, and few DAP12-positive microglia were detected.
Given that DAP12 is mainly expressed before P3 and that
glutamatergic synapses are generated post-natally [24], we
hypothesized that microglial dysfunction induced by DAP12
mutation has impacted the prenatal development of neurons with
delayed consequences on synaptic function. To test this hypothesis,
we cultured neurons from DAP12
KI and WT littermate P0 pups in
the presence of AraC, so as to eliminate microglia. Neurons were
grown for at least two weeks in culture to allow maturation of
glutamatergic synapses [25]. At that point, neuronal cultures were
more than 99% pure (supplementary data, Fig S2). Fluorometric
calcium imaging was used to monitor neuronal activity. Since
spontaneous activity was moderate in hippocampal cultures, all
recordings were performed in the presence of the potassium
channel blocker 4AP (50 mM) to increase the global network
activity. Under these conditions, neurons cultured from WT and
DAP12
KI P0 displayed similar activity (coefficient of variation of
calcium fluctuation in DAP12
KI cultures: 11564% of WT; Fig 2A).
Yet, in the presence of 6-cyano-7 nitroquinoxline-2 (CNQX), an
AMPAR antagonist, neuronal activity was significantly lower in
neurons cultured from mutant as compared with WT littermates
(coefficient of variation of calcium fluctuations in DAP12
KI
cultures: 6662% of WT; n.600; p,0,0001; Fig 2B). These
results are consistent with the enhanced AMPAR/NMDAR
currents ratio observed in vivo. They indicate that the contribution
of AMPARs to neuronal activity is increased in DAP12
KI neurons
cultured in the absence of microglia. This increased contribution
of AMPAR may possibly reflect an increased proportion of
excitatory synapses containing AMPA receptors. To test this,
glutamatergic synapses and AMPAR were identified by vesicular
glutamate transporter 1 (VGlut1) and by GluR1 immunoreactiv-
ities, respectively (Fig 2C). Figure 2D shows that the proportion of
excitatory synapses colocalized with GluR1-positive puncta was
significantly increased in cultures from mutant pups as compared
with WT pups (n.160; p,0.0001). In conclusion, neurons from
DAP12
KI P0 pups cultured in the absence of microglia exhibit an
enhanced relative contribution of AMPAR to excitatory transmis-
sion, which is compatible with the synaptic phenotype observed in
vivo. This demonstrates that microglial alteration due to DAP12
loss-of-function impacts neurons before birth, with delayed effects
on synaptic function.
DAP12 mutated microglia display a partial inflammatory
status
In order to understand how neurons from DAP12
KI mice are
perturbed prenatally, we characterized the effects of DAP12 loss-
of-function on the expression level of microglial genes encoding
proteins known to modulate synaptic or neuronal functions. As
shown in figure 3A, microglia cultured from DAP12
KI neonates
expressed higher levels of the mRNAs of the NO synthesizing
Synapses and Fetal Microglia
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IL6), all of which are inflammatory markers. The mRNA levels of
the chemokines CCL3 and CXCL2 slightly decreased (Fig 3A;
n=3; p,0.05). Finally, no change was observed in the expression
level of TNFa, another inflammatory marker, which regulates
AMPAR trafficking to synapses [26,27].
The overexpression of some, but not all inflammatory markers,
indicates that DAP12 loss-of-function induces a partial activation
phenotype in microglial cells. Inflammation is characterized by
expression of specific markers as well as increased proliferation. To
further characterize the inflammation status resulting from DAP12
mutation, we quantified the density of microglia in the
hippocampus of DAP12
KI and WT P0. We found that microglial
density was enhanced in the hippocampus of DAP12
KI P0 pups as
compared with WT at P0 (13466% of WT; p,0.001; Fig 3BC).
In the adult brain, however, the microglial cell density was not
different in DAP12
KI as compared with WT mice (DAP12
KI:
98612% of WT, Fig 3D). These data indicate that a partial and
transient inflammation occurs around birth in DAP12
KI mice.
This prenatal activation of microglia could thus be involved in the
delayed impaired synaptic function of DAP12
KI mice.
LPS-induced prenatal activation of microglia results in
delayed synaptic alterations
To test whether fetal activation of microglia could be sufficient
to induce delayed synaptic defects, we induced prenatal pharma-
cological inflammation and evaluated the consequences on
synaptic function.
In mice, the generation of hippocampal neurons starts at
around E14 [28], and microglia begin to invade parenchyma at
around E15 [29]. We thus choose to induce an inflammation at
E15. We induced inflammation by injecting a low dose (0,12 mg/
kg) of E. coli lipopolysaccharide (LPS) intraperitoneally into
pregnant dams. Low doses of lipopolysaccharide do not cross
Figure 1. DAP12 mutation induces an increased ratio of AMPAR vs. NMDAR currents in adult hippocampal slices, whereas DAP12 is
expressed only by microglia around birth. (A) Ratio of AMPAR vs. NMDAR currents in hippocampal slices. Left, original traces from individual
experiments. Right, averaged data from 9 and 10 recordings of WT and DAP12
KI mice, respectively, Mean6SEM, **p,0.03, Mann-Whitney t test. (B)
Double detection of DAP12 (upper line), of the microglial marker F4-80 (middle line), and overlay of both stainings (lower line), in the developing
hippocampus. DAP12 immunoreactivity is restricted to F4-80 positive cells. The fraction of microglia that express DAP12 (arrows: DAP12-positive
microglia) culminates at P0, when microglia are ameboid or poorly ramified. Postnatally, when microglia become ramified, they express less DAP12
and the fraction of DAP12-negative microglia (arrowheads) increases. At P7, very few DAP12-positive microglia are found (none in this picture). Scale
bar: 10 mm.
doi:10.1371/journal.pone.0002595.g001
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mediated by the injected agent itself, but rather by the maternal
immune response, possibly in coordination with fetal immune cells
[1,3,8,31]. This treatment did not alter the birth date or the size of
the litters (n=1264 and 1166 living pups per control and LPS-
injected dams, respectively; p=0.62, Student’s t test). To check
whether this treatment mimicked the inflammation in DAP12
KI
pups, we analyzed the microglial density in the offspring born to
LPS-injected mother. As shown in Figure 4B, microglial density
was increased in the hippocampus of P0 born to LPS-injected
dams (158618% of control; n=37 pairs of slices; p,0.001;
Fig 4AB). This increase was comparable with the one observed in
DAP12
KI pups (see above). We next evaluated the consequence of
such prenatal inflammation on glutamatergic transmission. To do
so, we first measured the ratio of AMPAR versus NMDAR EPSCs
in an adult born to inflamed mother. As in DAP12
KI mice, the
relative contribution of AMPAR to evoked EPSCs was enhanced
in hippocampal slices taken from adult mice that had been
subjected to fetal inflammation (AMPAR/NMDAR currents ratio:
Control: 0.1860.02 (n=9); LPS-treated mice: 0.2360.01 (n=10);
p,0.02; Fig 4C).
In order to evaluate whether LPS-induced prenatal inflamma-
tion also impairs synaptic function with delay, we analyzed the
neuronal activity of neurons cultured from P0 pups born to control
and to LPS-injected dams, both in the absence of microglia. In
basal conditions, neuronal activity, monitored by calcium
concentration fluctuations, was higher in neurons from maternally
inflamed P0, as compared with controls (13464% of control;
n.600; p,0.0001; Fig 5A). Yet, calcium fluctuations in the
presence of CNQX were significantly lower in neurons from
maternally inflamed P0 than from controls (6962% of control;
n.600; p,0.0001; Fig 5B). This resembles what we observed in
neurons cultured from DAP12
KI hippocampus. These results
demonstrate that prenatal activation of microglia, when also done
by pharmacological means, is sufficient to induce a delayed
increase in the contribution of AMPAR to excitatory neurotrans-
mission.
Discussion
In this work, we show that prenatal activation of microglia,
when both genetically and pharmacologically induced, has a
delayed impact on glutamatergic synaptic function in adult.
We previously showed that mutation of the microglial gene
DAP12 induced an enhanced long-term potentiation (LTP) and
modifications of glutamate receptors at synapses formed onto CA1
pyramidal cells [12]. In particular, we showed that these synapses
displayed a somehow immature phenotype, in which the
NMDARs were more sensitive to the NR2B-specific antagonist
ifenprodil, and the AMPARs more permeable to calcium as
compared with WT mice [12]. We have now observed that in
DAP12
KI mice, these synapses also display a higher ratio of
Figure 2. Neurons from DAP12
KI P0 pups cultured without microglia develop synaptic alterations. (A) Coefficients of variation (CV, see
Methods), in basal conditions, of the fluctuations of intracellular calcium concentration, in neurons cultured from WT and DAP12
KI animals. Left,
original recordings from individual neurites; right, averaged data from three independent experiments (.200 neurites recorded/experiment). (B)
Coefficients of variation in presence of CNQX, an AMPAR antagonist. Left, original recordings from individual neurites; right, averaged data from three
independent experiments (.200 neurites recorded/experiment); **p,0.0001 Mann-Whitney t test. (C) Double detection of VGlut1 (green or upper
line) and GluR1 (red or middle line) immunoreactivity, and overlay of both stainings (lower line) in neuronal cultures from WT and DAP12
KI animals.
Arrowheads: apposition of VGlut1 and GluR1 puncta; arrows: VGlut-1 puncta not apposed to GluR1 clusters. Scale bar: 5 mm. (D) Quantitative analysis
of VGlut-1 and GluR1 clusters association in four pairs of cultures from WT and DAP12
KI pups. At least 40 dendrites were analyzed for each culture.
**p,0.0001, two-way ANOVA.
doi:10.1371/journal.pone.0002595.g002
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AMPAR/NMDAR composition and properties and AMPAR/
NMDAR currents ratio has been reported in another kind of
synapses [22]. In DAP12
KI mice, the increased AMPAR to
NMDAR currents ratio may also synergistically result from the
increased density of perforated synapses that we measured, since
these synapses are especially enriched with AMPARs [23,32]. This
increased density was restricted to the medial segment of the apical
dendrites of CA1 neurons and may contribute to the EPSCs that
we monitored [33,34].
We previously proposed that the enhanced LTP in DAP12
KI
mice may be due to a larger fraction of silent, AMPAR-less,
synapses in mutant mice. Such hypothesis was based on
biochemical analysis of post-synaptic densities (PSD) that showed
a decreased content of AMPAR in DAP12
KI mice brain as
compared with WT. We did not observe this decrease in our
present analysis of hippocampal cultures and hippocampal
synapses morphology. This apparent discrepancy probably results
from the fact that in order to get an adequate amount of material,
the prior PSD analysis had been performed on whole cortex
extracts, and this may have occluded subtle modifications of
synaptic AMPARs restricted to the more specific regions under
investigation in our current study. Moreover, recent reports in the
literature have demonstrated that switching synaptic NR2B-
containing NMDARs with those containing NR2A, dramatically
reduces LTP [35]. Indeed, in DAP12
KI hippocampus, NMDAR
were sensitive to the NR2B-specific antagonist ifenprodil [12].
Thus, the enhanced LTP previously observed in DAP12
KI
hippocampus may be the consequence of the modifications of
NMDARs. In order to get an insight into the mechanism linking
DAP12 loss-of-function and neuronal phenotype, we characterized
the microglial alterations induced by the mutation. We showed
that DAP12
KI microglia cultured from P0 pups express higher
levels of inflammatory markers such as NOS-2, IL1b, and IL6, as
compared with their WT counterparts. The inflammatory status of
DAP12
KI was further confirmed by the detection of a transient
microgliosis in new-born, but not in adult mice brains. It has
recently been demonstrated that in peripheral macrophages,
DAP12 signaling is activator or inhibitor depending on the
inflammatory context [14,15]. It has been proposed that upon a
strong inflammatory stimulus such as a high level of LPS, DAP12
participates in activatory pathways, whereas at a low level of LPS,
DAP12 may preferentially recruit inhibitory mediators [14]. Our
data suggest that in the developing brain, DAP12 is a down-
regulator of microglial activation.
Neurons cultured from DAP12
KI or inflamed P0 pups that were
grown in a microglia-free and non-inflammatory environment
display altered synaptic function. This demonstrates that prenatal
inflammation suffices to alter synaptic function. However, this
does not exclude the possibility that prenatal inflammation also
has long-lasting effects on tissue and secondarily impacts neuronal
or synaptic dysfunction. For instance, adult mice born to inflamed
mother can display histological alterations [9,10] or impaired
neurogenesis [4], which may result in disturbance of neurotrans-
mission. Similarly, old DAP12-deficient mice display hypomyeli-
nosis in thalamus [36,37]. Such deficiencies demonstrate persistent
changes that we have not addressed in the present study. Together
with white matter alteration, a synaptic degeneration has been
described in the thalamus of DAP12-deficient mice, based on
abnormal vesicles accumulations observed by electron microscopy
[36]. We did not detect morphological alterations of synapses in
the hippocampus of DAP12
KI by electron microscopy (supple-
mentary data, Fig S1 A). Such a difference between the two studies
may be due to differences in age, in the genetic background of the
mice, or in the brain regions studied. Alternatively, the difference
may arise from the fact that the vesicle accumulations, described as
being a sign of synaptic degeneration [36], were not located in
synapses as defined by the apposition of vesicles, presynaptic dense
Figure 3. Microglia of DAP12
KI mice display a partially
activated phenotype at birth. (A) Quantitative analysis of the
expression of inflammatory markers in DAP12
KI microglia. Quantitative
RT-PCR performed on pure microglia cultured from brains of WT or
DAP12
KI P0 pups. The levels in the mutant microglial cultures are
expressed relative to the levels in the WT microglial cultures. n=3 pairs
of cultures. **p,0.05, Student’s t test. (B) F4/80 labeling of microglia
(arrows) in the hippocampus of WT and DAP12
KI pups. Scale bar:
100 mm. (C) Quantification of microglial density in the hippocampus of
WT and DAP12
KI animals at P0. Between 4 and 15 pairs of matched
slices were counted per experiment, n=3 experiments; **p,0.001, two-
way ANOVA. (D) Quantification of microglial density (Iba-1 positive cells)
at P20 (n=4 experiments).
doi:10.1371/journal.pone.0002595.g003
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these accumulations may correspond to features that have been
already described and are unrelated to synaptic dysfunction [38].
Prenatal inflammation is known to differentially impact adult
neuronal functions, depending on the inflammation-inducing
protocol [4]. In our study, we found that neurons cultured from
maternally-inflamed pups display enhanced basal neuronal activity
as compared with control. In contrast, basal activity was identical
in neurons from DAP12
KI and WT pups. This shows that the
genetical and pharmacological inductions of prenatal microglial
activation induce similar but not identical synaptic phenotypes.
Such a difference may be due to TNFa, whose mRNA is not
upregulated in DAP12
KI microglia, but which is a hallmark of
inflammation [4].
We have now shown that activation of microglia impacts
neurons prenatally, with a delayed effect on their synaptic
function. Deferred alteration of synaptic function depending on
prenatal development has already been observed. For example,
synaptic activity can be recorded on neurons from E18 rat
hippocampus cultured for two weeks, whereas it is barely detected
when neurons are cultured from E16 embryos [39]. This indicates
that prenatal differentiation of neurons is crucial for the later
development of synaptic function.
Epidemiological data have shown that infection during
pregnancy increases the risk of schizophrenia and autism in
adulthood [2,40]. In humans, mutations of DAP12 induce the
Nasu-Hakola disease, a presenile dementia that occurs in subjects
Figure 4. Maternal exposure to LPS induces microglial activation at birth and synaptic alterations in the adult offspring. (A) F4/80
labeling of microglia (arrows) in the hippocampus of P0 born from control (CTL) or LPS-injected dams (matLPS). (B) Quantification of microglial
density in the hippocampus at P0. Between 4 and 15 pairs of matched slices were counted per experiment, n=4 experiments; **p,0.001, two-way
ANOVA. Scale bar: 100 mm. (C) Increased ratio of excitatory AMPAR and NMDAR currents in hippocampal slices of adults born to control (CTL) or LPS-
injected (matLPS) dams. Left, original traces from individual experiments. Right, averaged data from n=9 CTL and 10 matLPS experiments; **p,0.02.
doi:10.1371/journal.pone.0002595.g004
Figure 5. Pharmacological activation of microglia during
embryonic development induces late synaptic alterations in
culture. (A) Coefficient of variation (CV, see Methods), in basal
conditions, of the fluctuations of intracellular calcium concentration,
in neurons cultured from pups born from control (CTL) or LPS-injected
(matLPS) dams. Averaged data from three independent experiments
(.200 neurites recorded/experiment); **p,0.0001 Mann-Whitney t
test. (B) Coefficient of variation in the presence of AMPAR antagonist
CNQX. Averaged data from three independent experiments (.200
neurites recorded/experiment) **p,0.0001 Mann-Whitney t test.
doi:10.1371/journal.pone.0002595.g005
Synapses and Fetal Microglia
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born to inflamed mothers display behavioral or cognitive deficits
reminiscent to some of the symptoms of autism and shizophrenia
[3,4,36]. Dementia are now mostly described as synaptopathies
[11], and alterations of glutamatergic synapses have been involved
in the etiology of autism [41]. In addition, hypofunction of
NMDAR has been implicated in the physiopathology of
schizophrenia [42,43]. Without excluding the involvement of
secondary histological alterations, the data presented in this work
provide a cellular basis for the neuropsychiatric defects induced by
prenatal inflammation.
Materials and Methods
Animals and LPS injection
DAP12
KI mice, also known as KD75 mice [13] are knocked-in
with an allele bearing a loss-of-function mutation in DAP12/
KARAP gene. They were backcrossed eight times with C57Bl/6J/
Rj mice. For each experiment, we used DAP12
KI and WT
littermates. Lipopolysaccharide (LPS, E. coli 055:B5; Sigma,
France) was injected intraperitoneally into pregnant Swiss mice
at 0.12 mg/kg, at day 15 of gestation. PBS injection was used as a
control. The experimental procedures were approved by the
Animal Experimentation Regional Ethics Committee in (p3-2007-
011 and p3-2005-012).
Cultures and quantitative RT-PCR
For neuronal cultures, hippocampi from P0 animals were
dissociated by trituration after incubation with papain. Cells were
grown in astrocyte-conditioned medium supplemented with 5 mg/
ml AraC (Calbiochem, France) to eliminate microglia and
astrocytes. Efficiency of AraC treatment was controlled both by
immunofluorescent stainings of cultures for the microglia-specific
F4/80 and astrocyte-specific GFAP markers, and by RT-PCR for
GFAP, Mac1 and NR1. Immunofluorescence showed that
neuronal cultures contained less than 0,7% of total glial cells after
8 days of culture (see Fig S2 for details). To minimize variations
attributable to potential fluctuations in culture conditions, we
compared neurons from DAP12
KI or WT and from maternally
inflamed or control P0 pups in sister cultures. For astrocytes
cultures, cortices from P1 Swiss pups were dissociated by
trituration after incubation with trypsin. Cells were grown in
MEM supplemented with horse serum. When confluence was
reached, this medium was replaced with Neurobasal medium
supplemented with B27 (Invitrogen, France). Three times a week,
this astrocyte-conditioned medium was removed, filtered and fed
to neurons, and replaced with fresh Neurobasal plus B27.
Microglia were cultured from P0 cortices and grown in DMEM
(Invitrogen, France) with FCS (BioWest, France). Microglia were
detached from the astrocytic layer after 12 days in vitro by gentle
shaking, settled on new plastic dishes, and processed after 24 hrs
for RNA purification (Ambion Europe, UK).
RNA was extracted using the MicroRNAqueous kit (Ambion
Europe, UK), treated with DNase and reverse-transcribed with
SuperScript II (Invitrogen, France). Quantitative PCR were
performed with the QuantiTect SYBR Green PCR kit (Qiagen,
France) on a LightCycler (Roche Diagnostics GmbH, Germany).
7SK RNA content was used for normalization. All primers were
designed with Primer3 [44].
Electrophysiology
Hippocampal slices were prepared from 18-25-day old WT
(n=14) and DAP12
KI (n=13) mice or from mice born to LPS
(n=9) or control PBS-injected (n=10) mothers, as described in
[12]. Whole-cell recordings were obtained from CA1 pyramidal
cells using borosilicate glass microelectrodes (2–5 MV) containing
115 mM CsMeSO3, 20 mM CsCl, 10 mM HEPES, 0.1 mM
EGTA, 4 mM Mg-ATP, 0.4 mM Na3-GTP and 10 mM Na-
phosphocreatine. EPSCs were evoked by extracellular stimulation
of Schaffer collateral afferents in the presence of 20 mM
bicuculline methochloride after a cut was made between the
CA3 and CA1 areas. AMPA- and NMDA-receptor mediated
currents were measured from recordings made at 260 and
+40 mV, respectively (270 and +40 mV in offspring of control
and LPS-injected mice). In order to compare AMPA/NMDA
currents ratios, stimulation intensities were adjusted to induce
EPSCs of similar amplitudes when recorded at 260 (or 270) mV.
Calcium imaging
Neurons grown for 20 days were loaded with Fluo4-AM
(Molecular Probes, France). Recordings (one image every 100 ms
for 10 seconds) were made on neurites in the presence of 50 mM
potassium channel blocker 4AP (Sigma Aldrich, Lyon, France) and
possibly CNQX (50 mM, Tocris Cookson, Bristol, UK). Changes
in the fluorescence level (F), normalized to the basal fluorescence
at the beginning of the recordings (F0), reflected intracellular
calcium fluctuations. The coefficients of variation (CV=standard
deviation/mean) of F/F0 were calculated with TI Workbench
Software (kindly provided by Takafumi Inoue, Waseda University,
Tokyo, Japan).
Immunostaining
Brain sections were obtained and processed as described in [12],
except for E17 embryo brains that were fixed by immersion in 4%
paraformaldehyde.
For immunohistochemistry, rat anti-F4/80 (Serotec, Oxford
UK) and rabbit anti-DAP12 (Chemicon, UK) primary antibodies
were incubated for 48 hrs at 4uC, then revealed by goat anti-rat-
Alexa488 (Molecular Probes, France) and donkey anti-rabbit-Cy3
(Jackson Immunoresearch Laboratories, USA) antibodies, respec-
tively.
For immunoperoxidase stainings, rat anti-F4/80 (Serotec,
Oxford UK) and rabbit anti-Iba-1 (Wako, Osaka, Japan) were
used as primary antibodies to label microglia at P0 and P20,
respectively; biotinylated anti-rat and anti-rabbit (Amersham
Health SA, France) were used as secondary antibodies, respec-
tively. Sections were revealed with avidin-biotin complex (Vectas-
tain ABC elite, Vector Laboratories, UK) and diaminobenzidine.
Only paired slices of DAP12
KI/WT, or CTL/LPS animals (same
position in hippocampus) were selected for analysis. At least six
pairs of slices were analyzed per experiment.
Cultured neurons were processed as described [12]. Primary
antibodies were guinea pig anti-VGlut1 and rabbit anti-GluR1
(both from Chemicon, UK), secondary antibodies were goat anti-
guinea pig-FITC and goat anti-rabbit-Cy3 (both from Jackson
Laboratories, West Grove, PA). Quantifications were performed as
described in [45].
Supporting Information
Figure S1 Increased density of perforated synapses in DAP12
KI
hippocampus. (A) Synapses, defined by the apposition of
presynaptic vesicles (v), synaptic cleft (c) and post-synaptic density
(p) were not different between WT and DAP12
KI. In particular, no
signs of synaptic degeneration. (B) Synaptic density in WT and
DAP12
KI hippocampus, measured in the stratum radiatum of the
hippocampus, at 50 to 200 mm of the pyramidal cell layer. 683+/
261 (WT) and 68+/218 (DAP12
KI) synapses were counted per
Synapses and Fetal Microglia
PLoS ONE | www.plosone.org 7 July 2008 | Volume 3 | Issue 7 | e2595animal. Results are mean+/2SD (n=3, p=0.33 t-test). (C) A
perforated synapse (double arrow) defined by a single bouton (v)
apposed with two post-synaptic densities (p). Note that the
membranes are collapsed between the post-synaptic densities.
(D) Quantification of the percentage of multiple synapses at 150 to
200 mm of the pyramidal cell layer. Results are mean6SD (n=3,
**p=0.004; t-test). No differences were observed from 50 to
150 mm (not shown). Scale bars=0.2 mm.
Found at: doi:10.1371/journal.pone.0002595.s001 (8.45 MB TIF)
Figure S2 Purity of hippocampal neuronal cultures treated with
AraC. A,B: Percentages of: (A) astrocytes (GFAP-positive), (B)
microglial cells (F4/80-positive), in neuronal cultures fixed after 2,
8 or 15 days of culture in presence of AraC. The total number of
cells was assessed with DAPI staining. n=150 to 550 cells were
counted per condition. Means6SD from 2 cultures are presented.
At 15 DIV, we counted 350 cells without finding any microglia,
indicating that the percentage of microglial cells was less than
0,3%. C: RT-PCR on neuronal (2, 8 or 13 days-old), astrocytic
(‘‘Astro.’’) or microglial (‘‘Mg.’’) cultures. ‘‘-RT’’: template without
reverse-transcriptase. Each PCR was performed on cDNA
corresponding to 3 ng of ARN. 30 cycles were used to amplify
the cDNA of: NR1 (NMDAR1, neuronal marker), GFAP (glial
fibrillary acidic protein, astrocytic marker), Iba1 (ionized calcium
binding adapter molecule 1, microglial marker). GFAP is barely
detected in 8 and 13 days-old neuronal cultures, whereas it is
detected in 2 days-old neuronal and in astrocytic cultures (positive
control). Iba1 is not detected in neuronal cultures, but is expressed
in the microglial culture (positive control).
Found at: doi:10.1371/journal.pone.0002595.s002 (0.79 MB TIF)
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